Gene · 1650
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63. | J Biol Chem | 2025 | 40345589 | PubTator, text mining | PubMed |
| The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells. | Mol Ther Oncol | 2025 | 40200920 | PubTator, text mining | PubMed |
| STT3B promotes porcine epidemic diarrhea virus replication by regulating N-glycosylation of PEDV S protein. | J Virol | 2025 | 39945486 | PubTator, text mining | PubMed |
| Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma. | BBA Adv | 2025 | 39911812 | PubTator, text mining | PubMed |
| Endocytosis, endoplasmic reticulum, actin cytoskeleton affected in tilapia liver under polystyrene microplastics and BDE153 acute co-exposure. | Comp Biochem Physiol C Toxicol Pharmacol | 2025 | 39725183 | PubTator, text mining | PubMed |
| N-glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer. | Adv Sci (Weinh) | 2025 | 39716927 | PubTator, text mining | PubMed |
| A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma. | Cell Death Differ | 2025 | 39690246 | PubTator, text mining | PubMed |
| Y chromosome sequencing data suggest dual paths of haplogroup N1a1 into Finland. | Eur J Hum Genet | 2025 | 39465313 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| A Mediterranean diet improves glycation markers in healthy people and in those with chronic diseases: a systematic review of clinical trials. | Nutr Rev | 2025 | 38719207 | PubTator, text mining | PubMed |
| Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines. | Front Microbiol | 2024 | 39943962 | PubTator, text mining | PubMed |
| Bone Fracture Incidence in Postmenopausal Women: Results of a 10 Year Follow Up in a RAC-OST-POL Study of rs1544410, rs7975232 and rs731236 Polymorphisms. | Nutrients | 2024 | 39683539 | PubTator, text mining | PubMed |
| Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial. | Cardiovasc Diabetol | 2024 | 39402581 | PubTator, text mining | PubMed |
| N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. | Glycobiology | 2024 | 39360848 | PubTator, text mining | PubMed |
| Induction of oxidative- and endoplasmic-reticulum-stress dependent apoptosis in pancreatic cancer cell lines by DDOST knockdown. | Sci Rep | 2024 | 39223141 | PubTator, text mining | PubMed |
| Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy. | Biochem Pharmacol | 2024 | 39218042 | PubTator, text mining | PubMed |
| Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and Safety. | J Med Chem | 2024 | 39136957 | PubTator, text mining | PubMed |
| Intercompatibility of eukaryotic and Asgard archaea ribosome-translocon machineries. | J Biol Chem | 2024 | 39128722 | PubTator, text mining | PubMed |
| Lycopene in Combination with Insulin Triggers Antioxidant Defenses and Increases the Expression of Components That Detoxify Advanced Glycation Products in Kidneys of Diabetic Rats. | Nutrients | 2024 | 38892513 | PubTator, text mining | PubMed |
| Smooth muscle NF90 deficiency ameliorates diabetic atherosclerotic calcification in male mice via FBXW7-AGER1-AGEs axis. | Nat Commun | 2024 | 38862515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1650/papers?page=3